LRG1 and melanoma: Consistent with this observation, data from The Human Protein Atlas (https://www.proteinatlas.org/, accessed on 23 April 2021) show that a higher expression of LRG1 is associated with poor three-year clinical outcomes in patients with melanoma (Figure 1B).